[1]
K. Wongbenjarat, “Central Nervous System Complications from Multiple Courses of the Monoclonal Antibbody Muromonab-CD3 (OKT3) Therapy: a Case Report”, MNRHJ, vol. 23, no. 1, pp. 39–48, Jan. 2025.